Does ERG Expression Predict Docetaxel Benefit in Prostate Cancer?

Tumor expression of the oncogene ERG might predict patient benefit from adding docetaxel to androgen deprivation therapy, according to analyses of two phase III clinical trials.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Conferences/ASCO Prostate Cancer News Source Type: news